FDA Warning Letter — Kolmar Korea Co. Ltd.
The FDA took a Warning Letter action against Kolmar Korea Co. Ltd. on May 18, 2018 (Sejong, South Korea). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action details
- Facility
- Kolmar Korea Co. Ltd.
- Date
- May 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Sejong (South Korea)